The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab

Med Sci Monit. 2012 Aug;18(8):LE9-10. doi: 10.12659/msm.883249.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / blood*
  • Asthma / drug therapy*
  • Humans
  • Omalizumab
  • Quality of Life*
  • Solubility
  • TNF-Related Apoptosis-Inducing Ligand / blood*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • TNF-Related Apoptosis-Inducing Ligand
  • Omalizumab